mounjaro eli lilly tirzepatide weight-loss drug appears to suppress binge-eating signal, small study finds Eli Lilly introduces Mounjaro (tirzepatide)
Description
Tirzepatide can still work, but the timeline to noticeable appetite suppression may be extended, and the degree of suppression may be moderated
In the pivotal SURPASS trials evaluating tirzepatide for type 2 diabetes, nausea occurred in 1222% of patients depending on the dose (5 mg, 10 mg, or 15 mg weekly), compared to approximately 58% with placebo
Boost Energy and Stamina
Back of Upper Arms The back of your upper arms, between your elbow and shoulder, offers an accessible injection site option for rotation
